Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Sep 30, 2021 5:09pm
234 Views
Post# 33947593

RE:Volume picked up a bit

RE:Volume picked up a bitNo doubt every scammer and basher worth his salt will be on this one this month. We are approaching announcements about efficacy in our latest patients, and with minimal side effects and no reported toxicity, it looks like the data will be very positive.
Fast Track Status has been achieved, and Breakthrough Status is within reach.
And that changes everything.
Those with strong hands will prevail.
What penny-flipping scammer wouldn't want a piece of this? It's going to be a very interesting fall and a new day in 2022.
GLTA!

fredgoodwinson wrote: with the price fall at the close.

Trusting that this afternoon`s 'sell' advice from the poster over on CEO was b/s rather than anything more substantive but it would be nice if we heard something - in fact anything - from our new CEO.


<< Previous
Bullboard Posts
Next >>